Showing results (831-840 of 1,245) with videos related to

Sort By:
Pageof 125
Journal of Cancer Survivorship : Research and Practice|March 1, 2014
It's who you know: patient-sharing, quality, and costs of cancer survivorship careCraig Evan Pollack, Kevin D Frick, Robert J Herbert, et al.
Cancer Chemotherapy and Pharmacology|October 25, 2011
Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trialEmmanuel S Antonarakis, Michael A Carducci, Mario A Eisenberger, et al.
Urology|May 30, 2001
Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomyW W Roberts, E J Bergstralh, M L Blute, et al.
Pediatric Pulmonology|September 22, 2021
Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/CF screen-positive, inconclusive diagnosisVito Terlizzi, Laura Claut, Carla Colombo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 7, 2009
Concordance of cancer patients' function, symptoms, and supportive care needsClaire F Snyder, Elizabeth Garrett-Mayer, Amanda L Blackford, et al.
Frontiers in Pediatrics|May 2, 2022
Psychological Impact of the COVID-19 Pandemic on Pregnant WomenDanilo Buonsenso, Walter Malorni, Arianna Turriziani Colonna, et al.
Clinical Genitourinary Cancer|May 27, 2017
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805])Roberto Pili, Opeyemi Jegede, Michael A Carducci, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2025
Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 DeficiencyFabio Bruschi, Ylenia Vaia, Clara E Antonello, et al.
American Journal of Clinical Oncology|August 8, 2006
Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinomaVictoria J Sinibaldi, Kathy Elza-Brown, Jill Schmidt, et al.
JAMA Oncology|May 26, 2018
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical TrialAndrew J Armstrong, Aseem Anand, Lars Edenbrandt, et al.
Pageof 125